Your browser doesn't support javascript.
loading
Comparison of the Efficacy and Safety of Warfarin and Antiplatelet Therapy in Patients with Atrial Fibrillation and End-Stage Renal Disease / 대한내과학회지
Korean Journal of Medicine ; : 191-199, 2019.
Artigo em Coreano | WPRIM | ID: wpr-741134
ABSTRACT
BACKGROUND/

AIMS:

The optimal strategy for anticoagulation treatment in patients with atrial fibrillation (AF) and end-stage renal disease (ESRD) has not been established. We evaluated the efficacy and bleeding risk of warfarin and antiplatelet agents in patients with AF and ESRD.

METHODS:

We retrospectively reviewed the medical records of 256 patients with AF and ESRD and included 158 patients (age, 63.7 ± 12.2 years; male sex, n = 103) with a CHA2DS2-VASc score ≥ 1 who were taking warfarin (n = 53) or an antiplatelet agent (n = 105).

RESULTS:

During the follow-up period (31.0 ± 29.4 months), 10 ischemic events and 29 major bleeding events occurred. The thromboembolic event rate did not significantly differ between the warfarin and antiplatelet groups (1.9% and 8.6%, respectively; p = 0.166). However, the rate of major bleeding events was significantly higher in the warfarin group than it was in the antiplatelet group (32.1% and 11.4%, respectively; p = 0.002). Cox's regression analysis indicated that warfarin was related to an increased risk of major bleeding events (hazard ratio [HR], 3.44; 95% confidence interval [CI], 1.60–7.36; p = 0.001). Conversely, warfarin was not related to a decreased risk of thromboembolic events (HR, 0.34; 95% CI, 0.04–2.70; p = 0.306).

CONCLUSIONS:

In patients with AF and ESRD, warfarin use was associated with an increased risk of bleeding events, compared with antiplatelet agents.
Assuntos

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Fibrilação Atrial / Varfarina / Inibidores da Agregação Plaquetária / Prontuários Médicos / Estudos Retrospectivos / Seguimentos / Hemorragia / Falência Renal Crônica / Anticoagulantes Tipo de estudo: Estudo observacional / Estudo prognóstico / Fatores de risco Limite: Humanos / Masculino Idioma: Coreano Revista: Korean Journal of Medicine Ano de publicação: 2019 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Assunto principal: Fibrilação Atrial / Varfarina / Inibidores da Agregação Plaquetária / Prontuários Médicos / Estudos Retrospectivos / Seguimentos / Hemorragia / Falência Renal Crônica / Anticoagulantes Tipo de estudo: Estudo observacional / Estudo prognóstico / Fatores de risco Limite: Humanos / Masculino Idioma: Coreano Revista: Korean Journal of Medicine Ano de publicação: 2019 Tipo de documento: Artigo